DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Building BlocksBuilding Blocks
  4. /Heterocyclic ScaffoldsHeterocyclic Scaffolds
  5. /Aromatic HeterocyclesAromatic Heterocycles
  6. /TegoprazanTegoprazan
Chemical structure of CAS 942195-55-3

Tegoprazan

CAS No.942195-55-3
MDL No.MFCD30533430
MFC20H19F2N3O3
MW387.40
InChI KeyCLIQCDHNPDMGSL-HNNXBMFYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.942195-55-3
Product NameTegoprazan

Biological Targets

ATP4A·ATP4B

Associated Conditions

Peptic ulcer·gastric ulcer·Helicobacter pylori infectious disease·duodenal ulcer·gastroesophageal reflux disease·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Tegoprazan, a Novel Potassium-Competitive Acid Blocker to Control Gastric Acid Secretion and Motility.

The Journal of pharmacology and experimental therapeutics • Vol. 364, Issue 2 • 2018
PMID: 29180359DOI: 10.1124/jpet.117.244202

Sea-blue histiocytes in a case of Takayasu arteritis.

JAMA • Vol. 235, Issue 26 • 1976
PMID: 6802

Documentation

Similar Products

  • (4R)-Tegoprazan

    CAS No.942195-56-4

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact